Your browser doesn't support javascript.
loading
Doxorubicin synergism and resistance reversal in human neuroblastoma BE(2)C cell lines: An in vitro study with dextran-catechin nanohybrids.
Vittorio, Orazio; Le Grand, Marion; Makharza, Sami A; Curcio, Manuela; Tucci, Paola; Iemma, Francesca; Nicoletta, Fiore Pasquale; Hampel, Silke; Cirillo, Giuseppe.
Afiliación
  • Vittorio O; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia; Australian Centre for NanoMedicine, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of New South Wales, NSW, Sydney, Australia.
  • Le Grand M; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia; Australian Centre for NanoMedicine, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of New South Wales, NSW, Sydney, Australia.
  • Makharza SA; College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine.
  • Curcio M; Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
  • Tucci P; Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
  • Iemma F; Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
  • Nicoletta FP; Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
  • Hampel S; Leibniz Institute of Solid State and Material Research Dresden, 01171 Dresden, Germany.
  • Cirillo G; Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy. Electronic address: giuseppe.cirillo@unical.it.
Eur J Pharm Biopharm ; 122: 176-185, 2018 Jan.
Article en En | MEDLINE | ID: mdl-29129733
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Doxorrubicina / Catequina / Dextranos / Resistencia a Antineoplásicos / Nanopartículas / Neuroblastoma Límite: Humans Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Doxorrubicina / Catequina / Dextranos / Resistencia a Antineoplásicos / Nanopartículas / Neuroblastoma Límite: Humans Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Países Bajos